While often referred to as if it were a single disease, arthritis is actually an umbrella term used for a group of more than 100 medical conditions that collectively affect nearly 46 million adults and 300,000 children in America alone. While the most common form of arthritis - osteoarthritis (OA) - is most prevalent in people over 60, arthritis in its various forms can start as early as infancy. Some forms affect people in their young-adult years as they are beginning careers and families and still others start during the peak career and child-rearing years.
The common thread among these 100-plus conditions is that they all affect the musculoskeletal system and specifically the joints - where two or more bones meet. Arthritis-related joint problems include pain, stiffness, inflammation and damage to joint cartilage (the tough, smooth tissue that covers the ends of the bones, enabling them to glide against one another) and surrounding structures. Such damage can lead to joint weakness, instability and visible deformities that, depending on the location of joint involvement, can interfere with the most basic daily tasks such as walking, climbing stairs, using a computer keyboard, cutting your food or brushing your teeth.
For many people with arthritis, however, joint involvement is not the extent of the problem. Many forms of arthritis are classified as systemic, meaning they can affect the whole body. In these diseases, arthritis can cause damage to virtually any bodily organ or system, including the heart, lungs, kidneys, blood vessels and skin. Arthritis-related conditions primarily affect the muscles and the bones.
Together, arthritis and related conditions are a major cause of disability in the United States, costing the U.S. economy more than $124 billion per year in medical care and indirect expenses such as lost wages and production - and costing millions of individuals their health, their physical abilities and, in many cases, their independence. And unless something changes, the picture is going to get worse. As the population ages, the number of people with arthritis is growing.
More Details
Thursday, March 22, 2007
Tuesday, March 20, 2007
Monday, February 05, 2007
Navamedic: final agreement with Gruenenthal for CEE
Navamedic, a Norwegian manufacturer of glucosamine-based products, has signed a final agreement with Gruenenthal, a pharma firm of German origin, for marketing and distribution of its glucosamine product Glucomed/Flexove for a range of Central and Eastern Europe (CEE) countries, including Poland.
The agreement was signed for a period of 10 years. The other countries covered by the agreement are the Czech Republic, Belarus, Kazakhstan, Slovakia, Russia and Ukraine. Austria may also be added to the seven countries already covered by the agreement. The companies signed a framework agreement for this market on 10 January, and the final agreement is expected to be formally signed before the end of March 2007.
Gruenenthal has already commenced the regulatory process in countries not part of the EU/EEA product approval process. Product launches are expected from 2007 in EU countries and 2008 in non-EU countries.
Navamedic announced that it had entered into a framework agreement with Gruenenthal on 29 September 2006. Prior to this, the Norwegian firm had been searching for a distribution partner since the product’s first approval at the beginning of the year, Navamedic CEO, Oyvind Brekke, revealed to Pharma Poland News in January 2006.
The agreement was signed for a period of 10 years. The other countries covered by the agreement are the Czech Republic, Belarus, Kazakhstan, Slovakia, Russia and Ukraine. Austria may also be added to the seven countries already covered by the agreement. The companies signed a framework agreement for this market on 10 January, and the final agreement is expected to be formally signed before the end of March 2007.
Gruenenthal has already commenced the regulatory process in countries not part of the EU/EEA product approval process. Product launches are expected from 2007 in EU countries and 2008 in non-EU countries.
Navamedic announced that it had entered into a framework agreement with Gruenenthal on 29 September 2006. Prior to this, the Norwegian firm had been searching for a distribution partner since the product’s first approval at the beginning of the year, Navamedic CEO, Oyvind Brekke, revealed to Pharma Poland News in January 2006.
Tuesday, January 30, 2007
SEO Firm is Responsible for Increasing the Business of Clients
New York, NY, January 30, 2007 --(PR.COM)-- Search engine optimization or, as it is called, SEO is concerned with adopting certain methods and techniques to improve the visibility of a website on search engine rankings. It is the duty of the best SEO firm to take due care of the plans that have to be chalked out for increasing the ranking of a website in search engine rakings. Comet Search Engine Marketing is a search engine optimization firm that works toward the benefits of its clients. Here, appropriate attention is given to each and every client.
There are lots of things that are a part of SEO process. Website designing is one such aspect that has to be handled with utmost attention. It is because the design of the site will catch the eyes of the visitor than any other thing. At Comet, it is taken care that color combination used is not at all gaudy, so that the visitors should not feel awkward. Generally, it is the face of the site that reflects the appeal. With creative web designers, Comet ensures that the client’s site is in safe hands. More>>
There are lots of things that are a part of SEO process. Website designing is one such aspect that has to be handled with utmost attention. It is because the design of the site will catch the eyes of the visitor than any other thing. At Comet, it is taken care that color combination used is not at all gaudy, so that the visitors should not feel awkward. Generally, it is the face of the site that reflects the appeal. With creative web designers, Comet ensures that the client’s site is in safe hands. More>>
Wednesday, November 01, 2006
WHAT IS BIOFLEX® STRONG GLUCOSAMINE & CHONDROITIN?
Strong Glucosamine Chondroitin with Multivitamins & Minerals
WHAT IS BIOFLEX® STRONG GLUCOSAMINE & CHONDROITIN?
Bioflex Strong Glucosamine & Chondroitin with Multivitamins & Minerals tablets is a far superior nutritional supplement than the other Bioflex products, formulated to help maintain healthy joints, cartilage, connective tissues and muscles; it combines joint preserving nutrients, which are all available in one easy to swallow tablet. Glucosamine sulphate plays an effective role in the production of collagen, the natural cushion in cartilage, it also increases synovial fluid, the substance between the joints that allows smoother movement for hips, knee’s and joints, without sufficient synovial fluid, the cartilage will tend to grind together and this may advance towards Osteoarthritus and Rheumatoid Arthritis.Chondroitin is also included in the formulation, as it works synergistically with the Glucosamine to help renew and repair cartilage, and maintain the lubricating properties of fluids around the joints. WHAT IS BIOFLEX STRONG GLUCOSAMINE & CHONDROITIN FOR? The complete combination is designed for people who are athletes or perform regular sporting activities that actively use their joints and need to maintain joint health. The role of Glucosamine & Chondroitin sulphate as research suggests, helps to support the surrounding structures that make up joint and cartilage, by feeding connective tissues, tendons, ligaments and muscle with Glucosamine and Chondroitin will help to strengthen overall joint health.The body's ability to manufacture Glucosamine naturally appears to decline with age, this is a reason for supplementation to be necessary regardless if you are young or old in order to support joint health at all times.
WHAT IS BIOFLEX® STRONG GLUCOSAMINE & CHONDROITIN?
Bioflex Strong Glucosamine & Chondroitin with Multivitamins & Minerals tablets is a far superior nutritional supplement than the other Bioflex products, formulated to help maintain healthy joints, cartilage, connective tissues and muscles; it combines joint preserving nutrients, which are all available in one easy to swallow tablet. Glucosamine sulphate plays an effective role in the production of collagen, the natural cushion in cartilage, it also increases synovial fluid, the substance between the joints that allows smoother movement for hips, knee’s and joints, without sufficient synovial fluid, the cartilage will tend to grind together and this may advance towards Osteoarthritus and Rheumatoid Arthritis.Chondroitin is also included in the formulation, as it works synergistically with the Glucosamine to help renew and repair cartilage, and maintain the lubricating properties of fluids around the joints. WHAT IS BIOFLEX STRONG GLUCOSAMINE & CHONDROITIN FOR? The complete combination is designed for people who are athletes or perform regular sporting activities that actively use their joints and need to maintain joint health. The role of Glucosamine & Chondroitin sulphate as research suggests, helps to support the surrounding structures that make up joint and cartilage, by feeding connective tissues, tendons, ligaments and muscle with Glucosamine and Chondroitin will help to strengthen overall joint health.The body's ability to manufacture Glucosamine naturally appears to decline with age, this is a reason for supplementation to be necessary regardless if you are young or old in order to support joint health at all times.
Subscribe to:
Posts (Atom)